Abbott Laboratories (ABT) Stock Forecast for 2024–2028. Sell or Buy Prediction







Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …

Abbott Laboratories (ABT) Stock Forecast for 2024–2028. Sell or Buy?

Updated: April 12, 2024 (08:42)

Sector: Healthcare

The share price of Abbott Laboratories (ABT) now

Latest session on the 12th of April for
Abbott Laboratories is negative
Trading Volume: 4041363
Open: 110.07 /  High: 110.5 /  Low: 108.492
What analysts predict: $126.74
52-week High/Low: $121.64 / $89.24

50/200 Day Moving Average: $114.89 / $106.66

This figure corresponds to the Average Price over the previous 50/200 days. For Abbott Laboratories stocks, the 50-day moving average is the resistance level today.

For Abbott Laboratories stocks, the 200-day moving average is the support level today.

Are you interested in Abbott Laboratories stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Abbott Laboratories stock price in 2024, 2025, 2026, 2027, 2028. How much will one Abbott Laboratories share be worth in 2024 - 2028?

When should I take profit in Abbott Laboratories stock? When should I record a loss on Abbott Laboratories stock? What are analysts' forecasts for Abbott Laboratories stock? What is the future of Abbott Laboratories stock? We forecast Abbott Laboratories stock performance using neural networks based on historical data on Abbott Laboratories stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Abbott Laboratories stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Abbott Laboratories shares. This happens once a day.


Historical and forecast chart of Abbott Laboratories stock

The chart below shows the historical price of Abbott Laboratories stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Abbott Laboratories stock price can be found in the table below.

Long-term forecasts by years.

Unlocking the Future: Navigating Abbott Laboratories' Stock Trends

Trend: Bullish
Mar 21, 2024

Investors and analysts constantly seek reliable indicators to forecast stock performance accurately. For Abbott Laboratories (ABT), several key factors can serve as a compass to navigate its stock price trends. Understanding the nuanced interplay of these elements provides valuable insights for both current and potential investors deliberating on whether ABT stock is a good buy or sell.

Crucial Drivers Shaping ABT's Financial Path

Firstly, Abbott Laboratories' financial performance, particularly its impressive fourth-quarter results, exceeds analyst expectations, signaling robust health and growth potential. This strong performance is a cornerstone for predicting ABT’s stock forecast with confidence, highlighting the company's adeptness at navigating market dynamics.

Moreover, Abbott's status as a Dividend King, boasting 52 consecutive years of dividend growth, is not just a historical footnote. It's a testament to the company's enduring profitability and strategic foresight. For those pondering, "Is ABT a good stock to buy?" the company's dividend reliability offers a compelling affirmative, making it an attractive option for income-seeking investors.

Lastly, innovation through recent product launches and relentless pursuit of research and development marks Abbott as a leader in its field. The success of products like the FreeStyle Libre and various structural hearts launches are pivotal in fueling Abbott's growth, thereby influencing the ABT stock price prediction positively.

  • Financial Performance
  • Dividend Growth
  • Product Launches and Innovation

By analyzing these facets meticulously, analysts can furnish a more nuanced and accurate ABT stock forecast, providing valuable guidance on whether it's the right time to buy or sell Abbott Laboratories stock. While no prediction is foolproof, focusing on these critical aspects offers a solid foundation for making informed investment decisions.

Review the original Analysis
About author

Unlocking the Future: Navigating ABT Stocks with Insight

Trend: Bullish
Feb 27, 2024

As an individual who has tried to crack the code of translating complexity into simplicity, understanding the subtleties influencing Abbott Laboratories (ABT) stock forecast becomes pivotal. The tapestry of factors poised to shape ABT's stock rates in the upcoming era paints an intriguing picture.

At the forefront, the increasing embrace of Continuous Glucose Monitoring (CGM) devices, bolstered by ABT's FreeStyle Libre system, seems to herald a new dawn. This trend isn't just about technological adoption; it's a narrative of how devices like FreeStyle Libre are becoming indispensably intertwined with diabetes management drugs such as Ozempic/Mounjaro. This synergy is expected to amplify patient care standards, translating into a bullish signal for those keen on making informed ABT stock price predictions.

Navigating Predictive Insights

To navigate the tide of stock fluctuations accurately, analysts might look into the mesh of optimistic FY2024 guidance, coupled with ABT's burgeoning profit margins. Such elements not only hint at a robust financial landscape but also offer a beacon for estimating stock price dynamics accurately. By leveraging insights into anticipated growth, fueled by R&D efficiency and enhanced operational protocols, analysts can sculpt a well-founded ABT stock price target, marking it as a potential buy or sell signal.

Fueling the attractiveness of ABT stocks further is the company’s compelling dividend investment thesis. With a commendable history of growth and coverage ratios, this aspect caters to those seeking a blend of income and capital appreciation—rendering a more holistic view on whether ABT is a good stock to buy.

In unwrapping the layers that inform the Abbott Laboratories stock forecast, it becomes clear that discerning analysts wield the rigor of these factors. Cataloging them from the growing adoption of Ozempic/Mounjaro and CGM devices, optimistic FY2024 foresight, to the strength of dividend appeal, offers a structured pathway to tapping into the pulse of ABT’s stock potential. Such a methodical approach stands as a testament to making predictions that are as accurate as they are actionable.

Review the original Analysis
About author

Abbott Laboratories manufactures drugs, medical devices and diagnostic tools – tests for immunity and blood tests that are used in clinics and hospitals in N countries. The first HIV test was developed by Abbott.

Business publications and major stock indices recognize Abbott Laboratories’ contributions: Fortune magazine has ranked the company as one of the most respected in the world every year since 1984.

The company was founded in 1888. The University of Michigan graduate Wallace Abbott worked as a medical practitioner and opened his own pharmacy. He introduced a new way of using alkaloids of medicinal plants: he formed granules from them with micro doses. Treatment with these granules helped patients because the doses of the drug were accurate and the effect was predictable and consistent.

Official site of the company

Abbott Laboratories daily forecast for a month

Date Target Pes. Opt. Vol., %
Apr 14 109.47 108.34 111.38 2.80
Apr 15 108.75 106.86 110.21 3.13
Apr 16 106.67 104.91 107.70 2.66
Apr 17 106.60 105.14 107.40 2.14
Apr 18 107.26 106.08 108.88 2.65
Apr 19 106.69 105.56 107.51 1.85
Apr 20 107.09 105.32 108.83 3.33
Apr 21 107.04 106.03 108.38 2.22
Apr 22 107.32 106.78 107.91 1.06
Apr 23 106.47 104.67 107.88 3.07
Apr 24 107.50 106.56 109.35 2.62
Apr 25 106.72 105.83 107.45 1.53
Apr 26 106.02 105.13 106.49 1.29
Apr 27 106.70 105.45 107.82 2.25
Apr 28 106.39 104.89 107.91 2.88
Apr 29 105.83 104.36 106.36 1.92
Apr 30 108.02 107.49 109.09 1.48
May 01 109.82 108.98 110.77 1.64
May 02 110.40 108.68 111.33 2.44
May 03 108.24 107.53 109.72 2.04
May 04 107.91 106.13 109.67 3.33
May 05 108.55 107.33 110.41 2.87
May 06 110.53 109.83 111.77 1.77
May 07 111.43 110.52 112.63 1.91
May 08 111.19 109.94 112.97 2.76
May 09 111.38 110.08 112.17 1.89
May 10 112.39 111.60 114.07 2.22
May 11 110.41 108.59 111.06 2.28
May 12 109.63 108.21 110.26 1.89
May 13 108.71 108.07 110.29 2.06

Abbott Laboratories Daily Price Targets


Abbott Laboratories Stock Forecast 04-14-2024.

Forecast target price for 04-14-2024: $109.47.
Negative dynamics for Abbott Laboratories shares will prevail with possible volatility of 2.724%.
Pessimistic target level: 108.34
Optimistic target level: 111.38

Abbott Laboratories Stock Forecast 04-15-2024.

Forecast target price for 04-15-2024: $108.75.
Negative dynamics for Abbott Laboratories shares will prevail with possible volatility of 3.040%.
Pessimistic target level: 106.86
Optimistic target level: 110.21

Abbott Laboratories Stock Forecast 04-16-2024.

Forecast target price for 04-16-2024: $106.67.
Negative dynamics for Abbott Laboratories shares will prevail with possible volatility of 2.592%.
Pessimistic target level: 104.91
Optimistic target level: 107.70

Abbott Laboratories Stock Forecast 04-17-2024.

Forecast target price for 04-17-2024: $106.60.
Negative dynamics for Abbott Laboratories shares will prevail with possible volatility of 2.097%.
Pessimistic target level: 105.14
Optimistic target level: 107.40

Abbott Laboratories Stock Forecast 04-18-2024.

Forecast target price for 04-18-2024: $107.26.
Positive dynamics for Abbott Laboratories shares will prevail with possible volatility of 2.579%.
Pessimistic target level: 106.08
Optimistic target level: 108.88

Abbott Laboratories Stock Forecast 04-19-2024.

Forecast target price for 04-19-2024: $106.69.
Negative dynamics for Abbott Laboratories shares will prevail with possible volatility of 1.812%.
Pessimistic target level: 105.56
Optimistic target level: 107.51

ABT (ABT) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
May. 117.48 114.10 121.53 6.11
Jun. 118.42 115.77 120.70 4.08
Jul. 123.16 116.56 129.57 10.04
Aug. 120.01 117.51 122.70 4.23
Sep. 124.71 120.92 131.40 7.97
Oct. 121.22 114.34 127.23 10.14
Nov. 121.51 118.69 126.08 5.86
Dec. 124.53 120.74 129.81 6.98

Abbott Laboratories forecast for this year


Abbott Laboratories Stock Prediction for May 2024

An uptrend is forecast for this month with an optimal target price of $117.484. Pessimistic: $114.10. Optimistic: $121.53


Abbott Laboratories Stock Prediction for Jun 2024

An uptrend is forecast for this month with an optimal target price of $118.424. Pessimistic: $115.77. Optimistic: $120.70


Abbott Laboratories Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $123.161. Pessimistic: $116.56. Optimistic: $129.57


Abbott Laboratories Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $120.008. Pessimistic: $117.51. Optimistic: $122.70


Abbott Laboratories Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $124.713. Pessimistic: $120.92. Optimistic: $131.40


Abbott Laboratories Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $121.221. Pessimistic: $114.34. Optimistic: $127.23


Abbott Laboratories Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $121.512. Pessimistic: $118.69. Optimistic: $126.08


Abbott Laboratories Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $124.525. Pessimistic: $120.74. Optimistic: $129.81



Abbott Laboratories (ABT) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 123.33 119.38 127.57 6.42
Feb 122.05 115.70 124.00 6.69
Mar 115.12 109.77 119.26 7.95
Apr 119.08 115.36 123.93 6.92
May 118.03 114.72 122.84 6.61
Jun 127.38 123.71 134.61 8.10
Jul 129.41 123.20 137.18 10.19
Aug 126.10 118.23 128.32 7.86
Sep 125.19 118.18 127.50 7.31
Oct 131.10 128.58 136.03 5.47
Nov 134.04 126.42 137.79 8.25
Dec 124.39 120.41 130.95 8.05

Abbott Laboratories (ABT) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 117.12 112.63 123.49 8.80
Feb 115.53 112.11 117.66 4.71
Mar 107.12 103.09 112.52 8.38
Apr 106.52 100.81 110.95 9.14
May 102.69 100.80 108.68 7.26
Jun 105.23 101.36 107.59 5.79
Jul 104.98 102.63 110.94 7.49
Aug 97.50 91.58 102.81 10.93
Sep 99.38 93.10 102.16 8.87
Oct 96.36 92.50 99.98 7.48
Nov 95.82 90.83 98.88 8.14
Dec 101.18 96.32 107.58 10.46

Abbott Laboratories (ABT) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 99.81 94.06 102.04 7.82
Feb 97.09 91.58 99.42 7.89
Mar 104.39 99.21 108.07 8.19
Apr 100.55 94.52 106.82 11.52
May 106.18 101.00 110.34 8.47
Jun 112.55 106.79 114.62 6.83
Jul 115.07 107.89 120.60 10.53
Aug 113.42 109.24 117.05 6.67
Sep 114.23 108.11 120.81 10.51
Oct 110.39 103.95 117.28 11.37
Nov 107.22 101.04 112.28 10.01
Dec 109.19 102.99 112.42 8.39

Abbott Laboratories (ABT) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 109.97 104.96 115.08 8.79
Feb 109.89 105.14 115.95 9.33
Mar 108.13 105.79 110.64 4.38
Apr 113.75 110.84 118.12 6.16
May 120.21 115.50 122.81 5.95
Jun 125.89 121.45 132.23 8.15
Jul 129.71 124.73 134.80 7.47
Aug 127.33 119.89 131.60 8.90
Sep 126.21 119.44 131.96 9.49
Oct 121.16 118.35 126.68 6.58
Nov 113.50 107.69 116.22 7.34
Dec 114.86 109.90 121.39 9.46

Abbott Laboratories information and performance

Abbott Laboratories Address

100 ABBOTT PARK ROAD, ABBOTT PARK, IL, US

Market Capitalization: 195 103 654 000 $

Market capitalization of the Abbott Laboratories is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ABT shares in the company outstanding by the market price of one share.

EBITDA: 10 463 000 000 $

EBITDA of Abbott Laboratories is earnings before interest, income tax and depreciation of assets.

PE Ratio: 34.49

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 39.38

Price/earnings to growth

DPS: 2.08

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0196

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 3.26

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.55
Quarterly Revenue Growth YOY: 0.015
Trailing PE: 34.49

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 22.42

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 5.07

Enterprise Value (EV) /Revenue

EV To EBITDA: 19.3

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 1735180000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Abbott Laboratories (ABT) stock dividend

Abbott Laboratories last paid dividends on 04/12/2024. The next scheduled payment will be on 05/15/2024. The amount of dividends is $2.08 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.